CME Cme Group Inc

Price (delayed)

$211.9

Market cap

$76.09B

P/E Ratio

39.68

Dividend/share

$3.5

EPS

$5.34

Enterprise value

$202.01B

CME Group Inc. is a global markets company. It is the world's largest financial derivatives exchange, and trades in asset classes that include agricultural products, currencies, energy, interest rates, metals, ...

Highlights
CME's P/E is 50% above its 5-year quarterly average of 26.4 and 31% above its last 4 quarters average of 30.4
The debt has grown by 41% since the previous quarter and by 22% year-on-year

Key stats

What are the main financial stats of CME
Market
Shares outstanding
359.1M
Market cap
$76.09B
Enterprise value
$202.01B
Valuations
Price to earnings (P/E)
39.68
Price to book (P/B)
2.87
Price to sales (P/S)
16.45
EV/EBIT
76.21
EV/EBITDA
65.15
EV/Sales
43.78
Earnings
Revenue
$4.61B
EBIT
$2.65B
EBITDA
$3.1B
Free cash flow
$2.38B
Per share
EPS
$5.34
Free cash flow per share
$6.64
Book value per share
$73.89
Revenue per share
$12.89
TBVPS
$360.82
Balance sheet
Total assets
$160.65B
Total liabilities
$134.1B
Debt
$126.86B
Equity
$26.53B
Working capital
$2.52B
Liquidity
Debt to equity
4.78
Current ratio
1.02
Quick ratio
1.01
Net debt/EBITDA
40.61
Margins
EBITDA margin
67.2%
Gross margin
100%
Net margin
41.5%
Operating margin
52.1%
Efficiency
Return on assets
1.4%
Return on equity
7.2%
Return on invested capital
2.6%
Return on capital employed
7.3%
Return on sales
57.4%
Dividend
Dividend yield
1.65%
DPS
$3.5
Payout ratio
65.5%

CME stock price

How has the Cme Group stock price performed over time
Intraday
1.21%
1 week
1.23%
1 month
-1.34%
1 year
25.43%
YTD
16.4%
QTD
-0.37%

Financial performance

How have Cme Group's revenue and profit performed over time
Revenue
$4.61B
Gross profit
$4.61B
Operating income
$2.4B
Net income
$1.91B
Gross margin
100%
Net margin
41.5%
The company's net income fell by 20% YoY and by 9% QoQ
The operating income is down by 18% YoY and by 9% QoQ
The gross profit has decreased by 11% YoY and by 6% from the previous quarter
CME's revenue is down by 11% year-on-year and by 6% since the previous quarter

Growth

What is Cme Group's growth rate over time

Valuation

What is Cme Group stock price valuation
P/E
39.68
P/B
2.87
P/S
16.45
EV/EBIT
76.21
EV/EBITDA
65.15
EV/Sales
43.78
CME's P/E is 50% above its 5-year quarterly average of 26.4 and 31% above its last 4 quarters average of 30.4
The EPS has declined by 20% year-on-year and by 9% since the previous quarter
CME's price to book (P/B) is 25% higher than its 5-year quarterly average of 2.3 and 20% higher than its last 4 quarters average of 2.4
The P/S is 25% higher than the 5-year quarterly average of 13.2 and 25% higher than the last 4 quarters average of 13.2
CME's revenue is down by 11% year-on-year and by 6% since the previous quarter

Efficiency

How efficient is Cme Group business performance
The ROIC has plunged by 52% YoY and by 13% from the previous quarter
Cme Group's return on assets has decreased by 46% YoY and by 18% QoQ
Cme Group's return on equity has decreased by 20% YoY and by 9% QoQ
The return on sales has declined by 7% year-on-year and by 2.9% since the previous quarter

Dividends

What is CME's dividend history
DPS
$3.5
Dividend yield
1.65%
Payout ratio
65.5%
Recent dividends

Financial health

How did Cme Group financials performed over time
Cme Group's total assets is 20% more than its total liabilities
Cme Group's total liabilities has increased by 36% QoQ and by 20% YoY
Cme Group's total assets has increased by 29% from the previous quarter and by 16% YoY
The debt has grown by 41% since the previous quarter and by 22% year-on-year
The debt to equity has grown by 39% from the previous quarter and by 22% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.